REMUS
Start SIP
Invest Now
Start SIP in REMUS
Performance
- Low
- ₹700
- High
- ₹700
- 52 Week Low
- ₹611
- 52 Week High
- ₹1,145
- Open Price₹700
- Previous Close₹710
- Volume100
- 50 DMA₹697.84
- 100 DMA₹734.31
- 200 DMA₹808.25
Investment Returns
- Over 1 Month -0.65%
- Over 3 Month -13.26%
- Over 6 Month -17.65%
- Over 1 Year -27.65%
Smart Investing Starts Here Start SIP with Remus Pharmaceuticals for Steady Growth!
Remus Pharmaceuticals Fundamentals Fundamentals refer to the financial data that companies report on a quarterly or annual basis.
- P/E Ratio
- 28.4
- PEG Ratio
- -
- Market Cap Cr
- 825
- P/B Ratio
- 2.7
- Average True Range
- 32.81
- EPS
- 24.53
- Dividend Yield
- 0.1
- MACD Signal
- -9.86
- RSI
- 53.31
- MFI
- 62.63
Remus Pharmaceuticals Financials
Remus Pharmaceuticals Technicals
EMA & SMA
Current Price
₹700.00
-10
(-1.41%)
- Bearish Moving Average 5
- Bullish Moving Average 11
- 20 Day
- ₹683.44
- 50 Day
- ₹697.84
- 100 Day
- ₹734.31
- 200 Day
- ₹808.25
Resistance and Support
700
- R3 700.00
- R2 700.00
- R1 700.00
- S1 700.00
- S2 700.00
- S3 700.00
Remus Pharmaceuticals Corporate Actions - Bonus, Splits, Dividends
| Date | Purpose | Remarks |
|---|---|---|
| 2025-11-10 | Quarterly Results & Interim Dividend | |
| 2025-05-17 | Audited Results, Dividend & Others | To consider 1. Bonus 2. Other business matters. Interim Dividend of Rs. 2 per equity share. |
| 2024-11-09 | Quarterly Results & Interim Dividend | To consider other business matters. Interim Dividend of Rs. 2 per equity share. |
| 2024-05-16 | Audited Results | |
| 2024-04-23 | Bonus issue & Interim Dividend |
Remus Pharmaceuticals F&O
About Remus Pharmaceuticals
- NSE Symbol
- REMUS
- BSE Symbol
- Managing Director
- Mr. Arpit Deepakkumar Shah
- ISIN
- INE0O5T01011
Similar Stocks to Remus Pharmaceuticals
Remus Pharmaceuticals FAQs
Remus Pharmaceuticals share price is ₹700 As on 13 February, 2026 | 06:16
The Market Cap of Remus Pharmaceuticals is ₹824.9 Cr As on 13 February, 2026 | 06:16
The P/E ratio of Remus Pharmaceuticals is 28.4 As on 13 February, 2026 | 06:16
The PB ratio of Remus Pharmaceuticals is 2.7 As on 13 February, 2026 | 06:16
Disclaimer: Investment in securities market are subject to market risks, read all the related documents carefully before investing. For detailed disclaimer please Click here.